|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.13 AUD | -.--% |
|
-.--% | -56.67% |
| 23/05 | Vectus Biosystems Appoints CTO | MT |
| 20/05 | Vectus Biosystems CEO Passes Away | MT |
Vectus Biosystems Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 0.648175 million compared to AUD 0.57927 million a year ago. Net loss was AUD 1.18 million compared to AUD 2.14 million a year ago.
Basic loss per share from continuing operations was AUD 0.0222 compared to AUD 0.0504 a year ago. Diluted loss per share from continuing operations was AUD 0.0222 compared to AUD 0.0504 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -56.67% | 45.93L | |
| +43.36% | 5.46TCr | |
| -5.31% | 3.99TCr | |
| +37.52% | 3.88TCr | |
| +14.75% | 2.69TCr | |
| -12.56% | 2.62TCr | |
| -22.45% | 1.88TCr | |
| +25.12% | 1.22TCr | |
| +0.04% | 1.22TCr | |
| +26.04% | 1.19TCr |
VECTUS BIOSYSTEMS LIMITED 
